Better Therapeutics Reports Fourth Quarter and Full Year 202

Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023

Reported positive topline results from exploratory trial for fatty liver disease

Announced restructuring and... | March 30, 2023

Related Keywords

United States , Americans , American , Frank Karbe , Drug Administration , American Heart Association , Company Announces Restructuring To Preserve Cash Runway , Nasdaq , Better Therapeutics Inc , World Evidence Program , American College Of Cardiology , Exchange Commission , Better Therapeutics , Recent Business , Accepted De Novo Request , Better Therapeutic , Additional Information , Clinical Trial Results , American Diabetes Association Produced , American College , Positive Topline Results , Exploratory Trial , Fatty Liver Disease , Livvita Liver Study , Nonalcoholic Fatty Liver Disease , Nonalcoholic Steatohepatitis , Magnetic Resonance Imaging , Proton Density Fat Fraction , Announces Restructuring To Preserve Cash Runway , Breakthrough Device Designation , Commercial Launch , Full Year , Hercules Capital , Breakthrough Device , Stockholder Equity , Nc Stock Exchange , News , Information , Press Release , Dvanced , Preparations , Or , Potential , Commercial , Launch , F , N , Positive , Topline , Results , Rom , Exploratory , Trial , Patty , Liver , Estructuring Bttx Us08773t1043 ,